Advertisement

Topics

Ozurdex works as adjunct treatment in diabetic macular edema

06:50 EDT 2 Aug 2017 | Healio

Patients with diabetic macular edema recalcitrant to anti-VEGF therapy and then treated with an intravitreal sustained-release 0.7 mg dexamethasone implant as part of a multimodal treatment experienced significant gains in visual acuity at a mean follow-up of 6 months, according to a study.DME is a multifaceted disease with ischemic and inflammatory mechanisms that can be treated with Ozurdex (dexamethasone intravitreal implant, Allergan), Zainab Khan, BHSc, MD, FRCSC, told Ocular Surgery News.

Original Article: Ozurdex works as adjunct treatment in diabetic macular edema

NEXT ARTICLE

More From BioPortfolio on "Ozurdex works as adjunct treatment in diabetic macular edema"

Quick Search
Advertisement
 

Relevant Topic

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...